A new technology is offering hope to men with low to intermediate-risk prostate cancer by providing a less invasive treatment ...

Michael Hoey admits he’s terrible at names. He used to call his kids “One, Two and Three.” When naming his startup seeking to ...

The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

A prostate cancer screening program involving participants in the top decile of risk according to a polygenic risk score ...

For men at the highest risk of prostate cancer as determined by a polygenic risk score, the percentage found to have ...

An at-home saliva test that assesses genetic risk of prostate cancer may be more accurate than PSA level or MRI.

This is the trouble with prostate cancer screening and why, despite ongoing pressure from charities, the National Screening ...

Of the 187 participants with cancer, 103 (55.1%) had prostate cancer classified as intermediate or higher risk according to the 2024 National Comprehensive Cancer Network (NCCN) criteria ...

A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was confirmed by data from a new study. Here is a roundup of March 2025 U.S. FDA ...

Dr Mohammad Mahmoud shares anticipated updates on evolving local treatments, PSMA-based therapies, and impactful genetic studies.

Discover the study that shows a new PRS spit test is more effective than the current UK prostate cancer screening pathway.

While this form of treatment is typically suggested for men with intermediate-risk prostate cancer, Kenigsberg said patients can ask their doctor whether the treatment is an option. “It’s not ...